CloudCraze Named a Strong Performer in B2B Commerce for Midsize Organizations by Independent Research Firm
CHICAGO, Sept. 14, 2017 (GLOBE NEWSWIRE) -- CloudCraze , an enterprise B2B commerce solution built natively on Salesforce, has been named a strong performer by Forrester, an independent research firm, in The Forrester Wave(TM): B2B Commerce Suites For Midsize Organizations, Q3 2017 . The company was cited for their relatively fast implementation time frame, B2B workflow management features, and easy system configurability. The report considers CloudCraze "a best fit for B2B customers that are looking to build on their investment in Salesforce and want to get up and running with an eCommerce solution quickly and easily."
"To us, Forrester's recognition of CloudCraze highlights our team's hard work and dedication over the past year to ensure the success of our clients," said Chris Dalton, CEO of CloudCraze. "After starting the year with a major round of funding, we've made significant investments in expanding our solution offerings and growing our implementation partner network, which have been noticed by numerous analysts over the past year. These enhancements, in tandem with our flexible, scalable commerce platform, make us a perfect fit for midsize B2B organizations."
The report also notes that CloudCraze "enables ready-made, Salesforce-centric eCommerce for midmarket B2B. Because it's deployed on the Salesforce PaaS, CloudCraze enables customers, in particular, to spin up commercial selling sites in short order." CloudCraze scored among the top three in the solution architecture and customer-facing digital touchpoints criteria, and was the only vendor to earn the highest available score in the implementation time frame criterion.
CloudCraze's cloud-based framework enables B2B companies to implement and deploy commerce quickly so they can start capitalizing on digital market growth. Its native Salesforce architecture allows companies to maximize their investments in Salesforce, gather and respond to customer feedback quickly and easily, and rapidly adapt to customer needs with new products and services.
"Companies will spend $2.4 billion on B2B commerce platforms over the next four years and approximately half of that amount with come from midsize companies. As B2B commerce spend grows among midsize organizations, we will continue to refine the CloudCraze solution to empower our customers to capitalize on this market," added Dalton. "The robust, flexible online experience that business buyers across industries demand will drive our investments in commerce on Salesforce now and in the future."
This announcement comes on heels of being named a strong performer in The Forrester Wave(TM): B2B Commerce Suites, Q1 2017 . For more information on CloudCraze's products or services, visit www.cloudcraze.com .
CloudCraze delivers robust B2B commerce native on Salesforce. It allows businesses to generate online revenue fast and easily scale for growth. Its Customer-First Commerce model puts the customer at the core, informing every interaction with data across commerce, sales, marketing, service and more. With the trusted Salesforce infrastructure and core capabilities, CloudCraze provides infinite flexibility to extend functionality, add products and channels, and conduct billions of dollars in transactions anywhere. CloudCraze powers Customer-First Commerce for high growth midsize companies such as ASCD, Avalara, Avid, Belnick, CSA Group, Candela, and Savant.
CloudCraze is funded by Insight Venture Partners and Salesforce Ventures. CloudCraze is recognized as a Visionary in the Gartner Magic Quadrant for Digital Commerce 2017. CloudCraze is a Salesforce Platinum ISV Partner.
Senior Account Executive
Senior Director, Marketing
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Oasmia Pharmaceutical AB21.9.2018 13:22 | pressemeddelelse
Oasmia Pharmaceutical Receives Positive CHMP Opinion for Apealea® (paclitaxel micellar) in the European Union
Patton Electronics Co.20.9.2018 22:17 | pressemeddelelse
Service Providers Speed Deployment, Reduce Costs with Patton Cloud Edge Orchestration Service
Taconic Biosciences20.9.2018 18:08 | pressemeddelelse
UPDATE— Taconic Biosciences Becomes the First Animal Model Provider on General Services Administration Contract Schedule
Anomali, Inc.20.9.2018 16:01 | pressemeddelelse
Anomali Launches Comprehensive Threat Platform to Detect and Respond to Cyber Attacks
Anomali, Inc.20.9.2018 16:01 | pressemeddelelse
Anomali Announces Major Expansion of Threat Platform Partner Ecosystem
Taconic Biosciences20.9.2018 15:41 | pressemeddelelse
Taconic Biosciences Becomes the First Animal Model Provider on Federal General Services Administration
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum